Skip to main content
Download PDF

Placental volume as a novel sign for identifying placenta accreta spectrum in pregnancies with complete placenta previa

BMC Pregnancy and Childbirth volume 24, Article number: 52 (2024) Cite this article

Abstract

Background

Placenta accreta spectrum (PAS) carries an increased risk of maternal-fetal mortality and morbidity, and magnetic resonance imaging (MRI) features for PAS have been used for preoperative identification. This study aims to investigate the role of placental volume evaluated by MRI in identifying PAS in pregnant women with complete placenta previa.

Methods

Totally 163 cases of complete placenta previa pregnant women with a history of cesarean section underwent MRI for suspected PAS were included. We categorized the patients into two groups according to the presence or absence of PAS, and the maternal-fetal perinatal outcomes and placental volume analyzed by 3D Slice software were compared.

Results

There were significantly more gravidity, parity, and number of previous cesarean delivery in the PAS group (P < 0.05). Significant differences were also found between the two groups with respect to the following baseline characteristics: gestational age at delivery, intraoperative blood loss, blood transfusion, and neonatal birth weight (P < 0.05). Of 163 women in the study, 7 (4.294%) required cesarean hysterectomy for high-grade PAS or pernicious bleeding during cesarean section, and PAS was confirmed with histologic confirmation in 6 (85.714%) cases. The placental volume in PAS group was greater than that in the non-PAS group (P < 0.05). With a threshold of more than 887 cm3, the sensitivity and specificity in identifying PAS were 85.531% and 83.907% respectively, with AUC 0.908 (95% CI: 0.853–0.948).

Conclusions

Placental volume may be a promising indicator of PAS in complete placenta previa patients with a history of cesarean section.

Peer Review reports

Introduction

Placenta accreta spectrum (PAS) is defined as abnormal attachment and adherence of the placenta to the uterus, which may result in severe maternal morbidity or death [1]. Over the past decades, with the increase of cesarean section rate, the incidence of PAS was also rising [2]. As a previous report described, cesarean deliveries were independent clinical risk factors of PAS [3]. Placenta previa is the highest risk factor for PAS, with an odds ratio (OR) value of 50.75 in these patients.[4] Furthermore, placenta previa with PAS can lead to higher maternal-fetal mortality and morbidity (premature delivery, massive hemorrhage, urinary tract injury and hysterectomy, etc.) than those without PAS [5, 6].

Antenatal diagnosis and assessment of the severity of the disease are critical to optimize delivery management, which could reduce mortality and morbidity. Currently, ultrasound is the preferred test for detecting PAS due to its low cost and high accuracy [7]. However, for posterior placenta, obese pregnant women and pregnant women with gastrointestinal pneumatosis, the advantages of magnetic resonance imaging (MRI) are more obvious [8]. The useful MRI features for PAS include placental thickness, dark intraplacental band on T2-weighted images (T2WIs), placenta-myometrial interface, placental heterogeneity, abnormal intraplacental vascularity, uterinebulging and so on [9, 10]. It also has been shown that the placental area have important impact on the clinical outcomes of patients with complete placenta previa [11]. However, placental volume of PAS is less studied. Moreover, more accurate MRI findings for predicting complete placenta previa with PAS are needed. In this context, this study aimed to investigate the relationship between placental volume and the likelihood of PAS in pregnancies with complete placenta previa with a history of cesarean section.

Materials and methods

Study Population and MRI Protocol

This study was approved by our institutional Ethics Review Board (Approval K-2022-015-K01). Informed consent was waived because of the retrospective nature of this study with anonymous selection, which did not subject the patients to new interventions. We reviewed the clinical data of complete placenta previa pregnant women with a history of cesarean section between January 2016 and December 2022. The inclusion criteria were as follows: (1) > 18 year old pregnant patients with complete placenta previa detected by ultrasound, (2) patients with suspected PAS disorders detected by both ultrasound and MRI in the third trimester, (3) patients with singleton pregnancy confirmed by early ultrasound before 15 weeks gestation, (4) with a history of more than one cesarean section. Exclusion criteria: (1) patients with twin or multiple pregnancies, (2) Patients conceived by assisted reproductive technology, (3) patients for whom MRI images were not retrieved on incomplete for evaluation, (4) poor image quality (motion artifacts, increased noise, wraparound artifacts, etc.).

Patients histories and intraoperative information was obtained from the electronic medical record system. The diagnosis of complete placenta previa was based on transabdominal ultrasound finding that the placental tissue completely covered the internal cervical os, and further MRI was performed if PAS was highly suspected. The included patients were classified into PAS and non-PAS groups based on FIGO criteria. Both clinical and histologic FIGO criteria were used to classify the grade of PAS, including grade 1 for accreta, grade 2 for increta, and grade 3 (3a, 3b and 3c) for percreta [12]. A pathologic diagnosis of PAS was identified on a review of hysterectomy specimens.

The MRI examinations without gadolinium were performed on 3 T (Siemens Medical Solutions, Erlangen, Germany) ranged from 31 to 34 gestational weeks. The pregnant women were asked to keep the urinary bladder moderately distended in order to evaluate the bladder-serosal interface during the MRI examination. Most patients were examined in the supine position and a small number of patients who could not tolerate this position examined in the left lateral decubitus position. MRI images were acquired using T2-weighted half-fourier acquisition single shot turbo spin echo (HASTE) sequence (repetition time 700 ms, echo time 87 ms, bandwidth 698 Hz/px, 432 × 432 matrix over a field of view of 380 × 380 mm, 5 mm slice thickness). The axial, sagittal and coronal planes were included with respect to the uterus.

The placental volume was independently measured by 2 radiologists specializing in obstetric and gynecologic imaging diagnosis (with more than 20 years of experience, respectively). The radiologists evaluated MRI images without knowledge of the clinical data of each patient. Interobserver measurements were compared for variability (kappa). The MRI images of patients with complete placenta previa were imported into 3D Slicer software (version 5. 2.1, www.slicer.org) in order to create placental profile and measure placental volume. The main steps were as follows: (1) import the patient’s original MRI images in DICOM format, (2) run the Editor module under the 2-dimensional window, (3) performe segmentations to trace the outer contours of the placenta manually on each slide, (4) use the 3-D segmentation function of the program, the placental volume of all included voxels were calculated (Fig. 1).

Fig. 1
figure 1

Placental volume was reconstructed in patients with complete placenta previa by 3D slicer software. A Sagittal MRI image with green color overlay from manual segmentation. B Axial MRI image with green color overlay from manual segmentation. C Coronal MRI image with green color overlay from manual segmentation. D Three-dimensional  placenta image generated by 3D Slicer using each manually segmented slice

Full size image

Statistical analysis

Continuous variables were expressed as mean ± standard deviation (SD) and categorical variables were summarised using counts and proportions. The statistical analysis included the t-Test, Chi-square, and receiver operating characteristic (ROC) curves. The ROC curve was analyzed to evaluate the area under the curve (AUC). Based on the ROC curve, the appropriate cut-off value set of placental volume, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated. The agreement between the two measurements was checked by kappa scores according to the following definitions: 1.0 perfect agreement, 0.91 to 0.99 almost perfect agreement, 0.81 to 0.90 substantial agreement, 0.71 to 0.80 moderate agreement, 0.61 to 0.70 fair agreement, and < 0.6 slight agreement. P value less than 0.05 were considered statistically significant. All statistical analyses were carried out using SPSS 23.0 statistics software (version 23.0, SPSS Inc., Chicago, IL, USA).

Results

In the current study, 163 women with at least 1 prior cesarean section received transabdominal ultrasound and MRI diagnosis of complete placenta previa and delivered at our institution. Of which 76 had confirmed PAS and 87 had simple complete placenta previa. Table 1 shows the clinical characteristics of these patients. There were significantly more gravidity, parity, and number of previous cesarean delivery in the PAS group (P < 0.05). Significant differences were also found between the PAS and non-PAS groups with respect to the following baseline characteristics: gestational age at delivery and neonatal birth weight. Women who had PAS had higher intraoperative blood loss (2502.829 ± 718.001 mL vs. 1951.713 ± 685.262 mL) and required more blood product transfusion (1940.487 ± 441.443 mL vs. 1353.103 ± 582.038 mL) compared to those without PAS (P < 0.001). Of 163 women in the study cohort, 7 (4.294%) required cesarean hysterectomy for high-grade PAS or pernicious bleeding during cesarean section, and PAS was confirmed with histologic confirmation in 6 (85.714%) cases. However, there were no statistical significances in terms of maternal age, BMI, previous history of placental previa, and gestational age at screening by MRI between the two groups.

Table 1 Patients clinical features of the study groups
Full size table

Here, 3D Slicer software was used to perform three-dimensional reconstruction and calculate the volume of placental volume (Figs. 1 and 2). There was good agreement for the measurement of placenta volume between the two radiologists (kappa = 0.938) (Table 2). The placental volume in PAS group was greater than that in the non-PAS group (P < 0.05) (Fig. 2A). According to clinical and histologic FIGO criteria of PAS, the depth of invasion was accreta or grade 1 in 35 (46.053%), increta or grade 2 in 26 (34.211%), and percreta or grade 3 in 15 (19.737%). As the grade increased in PAS patients according to FIGO criteria, the placental volume also increased(Fig. 2B). The sensitivity, specificity, PPV, and NPV of each placental volume cut-off value for the prediction of PAS were calculated and shown in Table 3. With a threshold of more than 887 cm3, the sensitivity and specificity in identifying PAS were 85.531% and 83.907% respectively, with AUC 0.908 (95% CI: 0.853–0.948) (Fig. 3).

Table 2 Interobserver reliability of magnetic resonance imaging (MRI) in the measurement of placental volume
Full size table
Fig. 2
figure 2

A. Placental volume between placenta accreta spectrum (PAS) and non-placenta accreta spectrum (non-PAS) group. B Placental volume in PAS patients with different grades by FIGO criteria

Full size image
Fig. 3
figure 3

Receiver operating characteristic (ROC) curve showing the predictive performance of placental volume for the occurrence of placenta accreta spectrum (PAS) in women with complete placenta previa with a history of cesarean section. With a threshold of more than 887cm3, the area under the curve (AUC) was 0.908 (95% CI: 0.853-0.948)

Full size image
Table 3 Cut-off levels of placental volume for the occurrence of placenta accreta spectrum (PAS).
Full size table

Discussion

PAS in complete placenta previa is a life-threatening obstetric complication, which can cause massive antepartum or postpartum hemorrhage for mothers. With the growth rate of cesarean deliveries, the incidence of PAS is also gradually increasing, prenatal diagnosis of PAS is vital. Accurate prenatal diagnosis of PAS can give obstetricians enough time to develop a multidisciplinary approach to delivery planning, which can decrease maternal and neonatal morbidity, including massive maternal hemorrhage and intensive care unit hospitalizations [13]. Thus, predicting PAS with high sensitivity and specificity for complete placenta previa is significantly useful in clinical settings. Prenatal diagnosis of PAS requires comprehensive analysis of risk factors and imaging data of pregnant women. In accordance with the literature, there are plenty of MRI features have been considered useful for predicting PAS, such as dark T2 bands, short cervix, abnormal uterine bulging, [14, 15] and so on. The international society for abnormally invasive placenta (IS-AIP) proposed several standard or agreement of MRI signs for PAS, including heterogeneous placenta, placental bulge, dark intraplacental bands, placental ischemic infarction, loss of retroplacental dark zone, and so on [16]. These MRI signs proposed by IS-AIP were high-risk signals for PAS. This study identified PAS by measuring placental volume, which might provide a new idea for screening PAS before cesarean section. As far as we know, there are no previous reports exploring the association between placental volume and PAS. We introduce a novel method for the analysis of PAS by measuring placental volume based on MRI.

Placenta previa and previous cesarean section are the most important independent risk factors for PAS [17]. PAS patients with the combination of placenta previa and a prior caesarean delivery have a higher risk of postpartum hemorrhage and hysterectomy [18]. Complete placenta previa was an obstetric complication different from incomplete placenta previa and associated with morbidity and mortality of the mother and neonate [19]. Therefore, the study population included in this study was women with complete placenta previa and a history of cesarean delivery. The main cause of PAS is the endometrium and myometrium damage caused by cesarean section. The trophoblast and villi may invade the myometrium and even pelvic organs through the endometrial defect of the uterine scar [20]. Jung EJ et al. [21] found that patients with placenta previa have large chorionic plate diameters and chorionic plate areas than normal pregnant women. The pathogenesis of abnormal placental vascularization is still under debate. Several studies have reported that the abnormally rich vascularity between the uterine scar and the placenta was observed in the first trimester of PAS patients [8, 22]. In patients with complete placenta previa, the placenta is attached to the lower uterine segment with poorly blood supply, and the compensatory growth of placental villi and increased placental volume are conducive to increased placental perfusion. The proliferated placental villi may implant in the myometrium and even penetrate the serosa layer of the uterus, which can allow the placenta and fetus to receive more blood supply and nutrition. Therefore, it is speculated that abnormal invasion of trophoblast and rich vascularity are important reasons for the increase of placental volume in PAS patients.

Most authors believe that the differentiation of placenta adherenta, increta and placenta percreta by MRI is challenging. Definitive MRI screening of PAS require findings of obvious placental extrauterine spread [23]. The previously reported sensitivity and specificity of MRI in the screening of PAS ranged from 75 to 100% and from 65 to 100%, respectively [9]. Rezk et al. [24] used dark intraplacental bands of MRI to predict PAS with a sensitivity and specificity of 92.73% and 76.00%, and the overall sensitivity and specificity was 96.08%, 87.50% by combining with three MRI features, respectively. In this study, women with PAS have larger placental volume than those women without PAS. When the placental volume cut-off value was 887 cm3, it showed excellent sensitivity (85.531%) and specificity (83.907%) for the identification of PAS, with excellent interobserver agreement (kappa = 0.938). The screening of PAS in most previous studies required the presence of multiple MRI parameters examined. Although the sensitivity and specificity are not the highest in this study, we did rely solely on placental volume, which could be quantified by 3D Slicer software. A key finding of our study is that measurements of the placental volume could provide additional information to assist us in identifying PAS. To our knowledge, this study is the first to test this imaging feature on MRI. In this study, the cases with PAS have more intraoperative blood loss compared with the group without PAS, which might have induced the higher frequency of hysterectomy. There were a low rate of hysterectomy in this study, which is due to an interprofessional team in managing PAS patients. Adequate preoperative evaluation and skilled surgical operation (uterine artery ligation, anti-arcuate compression suturing, and B-lynch suturing, etc.) of our team can significantly improve outcomes of mother and fetus [25]. The low rate of hysterectomy made histopathology difficult to perform in this study. Therefore, it was very necessary to diagnosis and classify PAS by the combination of clinical and histopathological criteria [26].

Limitations

The limitations of this study include the possibility of bias due to the retrospective nature of this study and the potential incidence of uterine dehiscence, which is considered in this study. Additional prospective studies are required to evaluate clinical and histopathological significance related with placental volume in predicting PAS.

Conclusion

In conclusion, placental volume based on MRI can be used to evaluate whether PAS is present in patients with complete placenta previa with a history of cesarean section.

Availability of data and materials

All data generated or analysed during this study are included in this published article.

Abbreviations

PAS:

Placenta accreta spectrum

MRI:

Magnetic resonance imaging

OR:

Odds ratio

T2WIs:

T2-weighted images

HASTE:

Half-fourier acquisition single shot turbo spin echo

SD:

Standard deviation

ROC:

Receiver operating characteristic

AUC:

Area under the curve

PPV:

Positive predictive value

NPV:

Negative predictive value

IS-AIP:

International society for abnormally invasive placenta

References

  1. Mogos MF, Salemi JL, Ashley M, et al. Recent trends in placenta accreta in the United States and its impact on maternal-fetal morbidity and healthcare-associated costs, 1998–2011. J Matern Fetal Neonatal Med. 2016;29:1077–82.

    Article  PubMed  Google Scholar 

  2. Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty year analysis. Am J Obstet Gynecol. 2005;192:1458–61.

    Article  PubMed  Google Scholar 

  3. Bowman ZS, Eller AG, Bardsley TR, et al. Risk factors for placenta accreta: a large prospective cohort. Am J Perinatol. 2014;31:799–804.

    PubMed  Google Scholar 

  4. Eshkoli T, Weintraub AY, Sergienko R, et al. Placenta accreta: risk factors, perinatal outcomes, and consequences for subsequent births. Am J Obstet Gynecol. 2013;208:219e211e7.

    Article  Google Scholar 

  5. Rosenberg T, Pariente G, Sergienko R, et al. Critical analysis of risk factors and outcome of placenta previa. Arch Gynecol Obstet. 2011;284:47–51.

    Article  PubMed  Google Scholar 

  6. Allen L, Jauniaux E, Hobson S, et al. FIGO consensus guidelines on placenta accreta spectrum disorders: nonconservative surgical management. Int J Gynaecol Obstet. 2018;140:281–90.

    Article  PubMed  Google Scholar 

  7. Comstock CH, Love JJ, Bronsteen RA, et al. Sonographic detection of placenta accreta in the second and third trimesters of pregnancy. Am J Obstet Gynecol. 2004;190:1135–40.

    Article  PubMed  Google Scholar 

  8. Lax A, Prince MR, Mennitt KW, et al. The value of specific MRI features in the evaluation of suspected placental invasion. Magn Reson Imag. 2007;25:87–93.

    Article  Google Scholar 

  9. Rahaim NS, Whitby EH. The MRI features of placental adhesion disorder and their diagnostic significance: systematic review. Clin Radiol. 2015;70:917–25.

    Article  CAS  PubMed  Google Scholar 

  10. Noda Y, Kanematsu M, Goshima S, et al. Prenatal MR imaging diagnosis of placental invasion. Abdom Imaging. 2015;40:1273–8.

    Article  PubMed  Google Scholar 

  11. Zhou L, Zhao X, Xu D, et al. Placental area in the Lower Uterine segment, cervical length, and clinical outcome in pregnancies with complete placenta previa. J Magn Reson Imaging. 2023;58(4):1047–54.

    Article  PubMed  Google Scholar 

  12. Jauniaux E, Ayres–De–Campos D, Langhoff–Roos J, et al. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2019;146:20–4.

    Article  PubMed  Google Scholar 

  13. Eller AG, Bennett MA, Sharshiner M, et al. Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care. Obstet Gyneco. 2011;l17:331–7.

    Article  Google Scholar 

  14. Cuthbert F, Vinas MT, Whitby E. The MRI features of placental adhesion disorder—a pictorial review. Br J Radiol. 2016;89: 20160284.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Mar WA, Berggruen S, Atueyi U, et al. Ultrasound imaging of placenta accreta with MR correlation. Ultrasound Q. 2015;31:23–33.

    Article  PubMed  Google Scholar 

  16. Morel O, Collins SL, Uzan-Augui J, et al. A proposal for standardized magnetic resonance imaging (MRI) descriptors of abnormally invasive placenta (AIP) - from the International Society for AIP. Diagn Interv Imaging. 2019;6:319–25.

    Article  Google Scholar 

  17. Jitsumori M, Matsuzaki S, Endo M, et al. Obstetric outcomes of pregnancy after uterine artery embolization. Int J Womens Health. 2020;2:151e8.

    Google Scholar 

  18. Kayem G, Seco A, Beucher G, et al. Clinical profiles of placenta accreta spectrum: the PACCRETA population-based study. BJOG. 2021;128:1646–55.

    Article  CAS  PubMed  Google Scholar 

  19. Tuzovic L. Complete versus incomplete placenta previa and obstetric outcome. Int J Gynaecol Obstet. 2006;93:110–7.

    Article  CAS  PubMed  Google Scholar 

  20. Jauniaux E, Collins S, Burton GJ. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol. 2018;218:75e87.

    Article  Google Scholar 

  21. Jung EJ, Cho HJ, Byun JM, et al. Placental pathologic changes and perinatal outcomes in placenta. Placenta. 2018;63:15–20.

    Article  PubMed  Google Scholar 

  22. D’Antonio F, Timor-Tritsch IE, Palacios-Jaraquemada J, et al. First trimester detection of abnormally invasive placenta in high-risk women: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018;51(2):176e83.

    Google Scholar 

  23. Kilcoyne A, Shenoy-Bhangle AS, Roberts DJ, et al. MRI of placenta accreta, placenta increta, and placenta percreta: pearls and pitfalls. AJR Am J Roentgenol. 2017;208:214–21.

    Article  PubMed  Google Scholar 

  24. Rezk MA-A, Shawky M. Grey-scale and colour doppler ultrasound versus magnetic resonance imaging for the prenatal diagnosis of placenta accreta. J Matern Fetal Neonatal Med. 2016;29:218–23.

    Article  PubMed  Google Scholar 

  25. Li Y, Luan X, Chen D, et al. Use of anti-arcuate compression suturing in pernicious placenta previa with accrete spectrum disorders: a surgical technique. Med Sci Monit. 2020;26:e922958.

    Article  PubMed  Google Scholar 

  26. Jauniaux E, Hussein AM, Zosmer N, et al. A new methodologic approach for clinico-pathologic correlations in invasive placenta previa accreta. Am J Obstet Gynecol. 2020;222:379e1-3711.

    Article  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

We thank the participants and clinical site staff for their contributions to this study. This study was supported by Maternal and children’s health research project of Jiangsu Province (grant number F202108), Suzhou Science and Technology Plan Research Project (grant number SKJYD2021222, SYSD2020133, SKY2021056), and the Clinical Medical Expert Team Project of Suzhou (grant number SZYJTD201709).

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, No. 26 Daoqian Street, Gusu District, Suzhou, 215002, Jiangsu, China

    Yongfei Yue, Xiaoyan Wang, Liping Zhu, Chengfeng Liu, Dali Chen & Baoquan Liang

  2. Department of Medical Imaging, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, Jiangsu, China

    Yanli Lu

Authors
  1. Yongfei Yue
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiaoyan Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Liping Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chengfeng Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dali Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yanli Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Baoquan Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

YFY designed the study and drafted/revised the manuscript. XYW and LPZ made contributions to the acquisition of clinical study data. CFL analysed the imaging data. DLC, YLL and BQL made substantial contributions to the analysis and interpretation of the data.

Corresponding author

Correspondence to Yongfei Yue.

Ethics declarations

Ethics approval and consent to participate

This prospective study was approved by the Ethics Review Board of the affiliated Suzhou Hospital of Nanjing Medical University (Approval K-2022-015-K01). The study was conducted according to the principles of the Declaration of Helsinki. All participants were informed about the study, and written informed consent was obtained from each of them.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yue, Y., Wang, X., Zhu, L. et al. Placental volume as a novel sign for identifying placenta accreta spectrum in pregnancies with complete placenta previa. BMC Pregnancy Childbirth 24, 52 (2024). https://doi.org/10.1186/s12884-024-06247-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12884-024-06247-y

Keywords

BMC Pregnancy and Childbirth

ISSN: 1471-2393

Contact us